|Other Names||Thrombopoietin, C-mpl ligand, ML, Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, MGDF, Myeloproliferative leukemia virus oncogene ligand, THPO, MGDF|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP6254a was selected from the N-term region of human TPO . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Lineage-specific cytokine affecting the proliferation and maturation of megakaryocytes from their committed progenitor cells. It acts at a late stage of megakaryocyte development. It may be the major physiological regulator of circulating platelets.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Megakaryocytopoiesis is the cellular development process that leads to platelet production. TTPO is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. This protein is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene.
Hirayama, Y., et al., Am. J. Hematol. 73(4):285-289 (2003).Webb, K.E., et al., Exp. Hematol. 31(6):488-494 (2003).Tsao, P.N., et al., Biol. Neonate 82(4):217-221 (2002).Hsu, H.C., et al., Oncology 63(1):64-69 (2002).Holmes, M.L., et al., J. Biol. Chem. 277(50):48333-48341 (2002).
If you have any additional inquiries please email technical services at email@example.com.